Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15599 | 28821440 | Cell Signal | Apelin protects against liver X receptor-mediated steatosis through AMPK and PPARα in human and mouse hepatocytes. | 2017 | Details |
| A15600 | 28820447 | Int J Mol Sci | Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats. | 2017 | Details |
| A15601 | 28820393 | J Physiol Pharmacol | Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver disease. | 2017 | Details |
| A15602 | 28817690 | PLoS One | Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats. | 2017 | Details |
| A15603 | 28817367 | Nutr Clin Pract | Nutrition Implications for Long-Term Survivors of Pancreatic Cancer Surgery [Formula: see text]. | 2017 | Details |
| A15604 | 28816082 | J Asian Nat Prod Res | Zeaxanthin dipalmitate alleviates hepatic injury induced by superimposed chronic hepatitis B and non-alcoholic steatohepatitis in non-obese mice. | 2017 | Details |
| A15606 | 28815679 | Clin Exp Pharmacol Physiol | (-)-Epigallocatechin-3-gallate and atorvastatin treatment down-regulates liver fibrosis-related genes in non-alcoholic fatty liver disease. | 2017 | Details |
| A15607 | 28814531 | J Nutr | Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation. | 2017 | Details |
| A15608 | 28812576 | Eur J Clin Nutr | Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study. | 2017 | Details |
| A15609 | 28811715 | World J Gastroenterol | Sex-influenced association of non-alcoholic fatty liver disease with colorectal adenomatous and hyperplastic polyps. | 2017 | Details |
| A15610 | 28811690 | Indian J Clin Biochem | Biochemical Profile of Nonalcoholic Fatty Liver Disease Patients in Eastern India with Histopathological Correlation. | 2016 | Details |
| A15611 | 28811651 | Int J Obes (Lond) | iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner. | 2017 | Details |
| A15612 | 28811572 | Sci Rep | Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice. | 2017 | Details |
| A15613 | 28811064 | Ultrasound Med Biol | Evaluation of Non-alcoholic Fatty Liver Disease Using Acoustic Radiation Force Impulse Imaging Elastography in Rat Models. | 2017 | Details |
| A15614 | 28809804 | Nutrients | Type 1 Diabetes and Non-Alcoholic Fatty Liver Disease: When Should We Be Concerned? A Nationwide Study in Brazil. | 2017 | Details |
| A15615 | 28809727 | Ann Hepatol | Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine. | 2018 | Details |
| A15616 | 28807841 | Gastroenterology | Racial Disparity in Gastrointestinal Cancer Risk. | 2017 | Details |
| A15617 | 28805745 | Children (Basel) | Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics. | 2017 | Details |
| A15618 | 28805669 | Nutrients | Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study. | 2017 | Details |
| A15620 | 28804947 | J Clin Periodontol | Periodontitis and Non-alcoholic Fatty Liver Disease, a population-based cohort investigation in the Study of Health in Pomerania. | 2017 | Details |
| A15621 | 28804621 | Biomed Rep | Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease. | 2017 | Details |
| A15623 | 28803953 | J Hepatol | Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. | 2017 | Details |
| A15624 | 28803504 | Expert Rev Clin Pharmacol | The pharmacological management of NAFLD in children and adolescents. | 2017 | Details |
| A15625 | 28802640 | Clin Chim Acta | Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins. | 2017 | Details |
| A15626 | 28802566 | Gastroenterology | Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15627 | 28802563 | Gastroenterology | Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride Synthesis in Liver and Muscle Tissues. | 2017 | Details |
| A15628 | 28802074 | Hepatology | Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance. | 2017 | Details |
| A15629 | 28802062 | Hepatology | Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. | 2017 | Details |
| A15630 | 28800087 | Children (Basel) | Imaging Features of Non-Alcoholic Fatty Liver Disease in Children and Adolescents. | 2017 | Details |
| A15631 | 28799803 | Crit Rev Food Sci Nutr | Nutrition, inflammation and liver-spleen axis. | 2017 | Details |
| A15632 | 28799714 | Mol Nutr Food Res | Potential Biological Effects of (-)-Epigallocatechin-3-gallate on the Treatment of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15633 | 28797988 | Turk J Gastroenterol | Effects of long-term synbiotic supplementation in addition to lifestyle changes in children with obesity-related non-alcoholic fatty liver disease. | 2017 | Details |
| A15634 | 28797121 | PLoS One | Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2. | 2017 | Details |
| A15635 | 28797077 | PLoS One | Gender difference in NASH susceptibility: Roles of hepatocyte Ikkβ and Sult1e1. | 2017 | Details |
| A15636 | 28796993 | Digestion | Oral Administration of CardioAid and Lunasin Alleviates Liver Damage in a High-Fat Diet Nonalcoholic Steatohepatitis Model. | 2017 | Details |
| A15637 | 28796629 | Environ Health Perspect | Hepatic Lipid Accumulation and Nrf2 Expression following Perinatal and Peripubertal Exposure to Bisphenol A in a Mouse Model of Nonalcoholic Liver Disease. | 2017 | Details |
| A15638 | 28796410 | Liver Int | Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease. | 2017 | Details |
| A15639 | 28796299 | Eur J Clin Invest | Complement C3 and fatty liver disease in Rheumatoid arthritis patients: a cross-sectional study. | 2017 | Details |
| A15640 | 28796060 | Medicine (Baltimore) | Candidate genes investigation for severe nonalcoholic fatty liver disease based on bioinformatics analysis. | 2017 | Details |
| A15641 | 28795140 | Transplant Direct | Resting and Exercise Energy Metabolism After Liver Transplantation for Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15642 | 28791556 | Dig Dis Sci | The Clinical Implications of Fatty Pancreas: A Concise Review. | 2017 | Details |
| A15643 | 28791501 | J Gastroenterol | Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease. | 2017 | Details |
| A15644 | 28790228 | Acta Med Indones | Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis. | 2017 | Details |
| A15645 | 28790222 | Acta Med Indones | Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors. | 2017 | Details |
| A15647 | 28790196 | Sci Signal | TRIF-dependent Toll-like receptor signaling suppresses Scd1 transcription in hepatocytes and prevents diet-induced hepatic steatosis. | 2017 | Details |
| A15648 | 28789977 | Biochim Biophys Acta Mol Basis Dis | Ablation of systemic SIRT1 activity promotes nonalcoholic fatty liver disease by affecting liver-mesenteric adipose tissue fatty acid mobilization. | 2017 | Details |
| A15649 | 28789631 | BMC Gastroenterol | Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. | 2017 | Details |
| A15650 | 28787358 | J Clin Gastroenterol | The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients. | 2018 | Details |
| A15651 | 28786388 | Lancet Gastroenterol Hepatol | Wolman's disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency. | 2017 | Details |
| A15652 | 28783409 | Int Rev Immunol | Host defenses against metabolic endotoxaemia and their impact on lipopolysaccharide detection. | 2017 | Details |
| A15654 | 28781785 | Mol Clin Oncol | Effect of age on the development of chemotherapy-associated liver injury in colorectal cancer liver metastasis. | 2017 | Details |
| A15655 | 28781602 | Nutr Metab (Lond) | eIF2α phosphorylation is required to prevent hepatocyte death and liver fibrosis in mice challenged with a high fructose diet. | 2017 | Details |
| A15656 | 28777914 | Can J Physiol Pharmacol | Resveratrol improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins, free fatty acid oxidation, and intestinal triglyceride absorption. | 2017 | Details |
| A15658 | 28777879 | Hepatology | Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis. | 2017 | Details |
| A15659 | 28777871 | Hepatology | A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation. | 2017 | Details |
| A15660 | 28777831 | PLoS One | Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis. | 2017 | Details |
| A15661 | 28777296 | Nutrients | Serum Iron:Ferritin Ratio Predicts Healthy Body Composition and Reduced Risk of Severe Fatty Liver in Young Adult Women. | 2017 | Details |
| A15666 | 28776154 | Obes Surg | Sleeve Gastrectomy After Liver Transplantation: Feasibility and Outcomes. | 2018 | Details |
| A15667 | 28776153 | Obes Surg | Visual Liver Score to Stratify Non-Alcoholic Steatohepatitis Risk and Determine Selective Intraoperative Liver Biopsy in Obesity. | 2018 | Details |
| A15668 | 28775758 | Nutr Metab (Lond) | Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults. | 2017 | Details |
| A15669 | 28775179 | BMJ Open | Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model. | 2017 | Details |
| A15670 | 28775168 | Cancer Res | JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity. | 2017 | Details |
| A15671 | 28774887 | Gut | Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. | 2017 | Details |
| A15672 | 28774869 | Am J Physiol Gastrointest Liver Physiol | Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis. | 2017 | Details |
| A15673 | 28774777 | Mol Cell Endocrinol | Insights into the role of hepatocyte PPARα activity in response to fasting. | 2017 | Details |
| A15674 | 28772340 | J Viral Hepat | Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study. | 2017 | Details |
| A15675 | 28771824 | J Cell Biochem | Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR/S6K1 signaling pathway. | 2017 | Details |
| A15677 | 28770225 | Biomed Res Int | PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway. | 2017 | Details |
| A15678 | 28768719 | FASEB J | The specialized proresolving lipid mediator maresin 1 protects hepatocytes from lipotoxic and hypoxia-induced endoplasmic reticulum stress. | 2017 | Details |
| A15679 | 28768172 | Cell Metab | Sweet Sixteenth for ChREBP: Established Roles and Future Goals. | 2017 | Details |
| A15680 | 28767558 | Ann Surg | Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial. | 2017 | Details |
| A15681 | 28767077 | Children (Basel) | Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15682 | 28763870 | Zhonghua Gan Zang Bing Za Zhi | [Effect of liraglutide in treatment of non-alcoholic fatty liver disease: mechanism of action and research advances]. | 2017 | Details |
| A15683 | 28763845 | Zhonghua Gan Zang Bing Za Zhi | [Sivelestat alleviates nonalcoholic steatohepatitis in mice through inhibiting activation of Kupffer cells]. | 2017 | Details |
| A15684 | 28761689 | BMJ Open Gastroenterol | Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review. | 2017 | Details |
| A15685 | 28760353 | Clin Res Hepatol Gastroenterol | Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: Association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation. | 2017 | Details |
| A15686 | 28759939 | Horm Metab Res | Effects of a Low-Calorie, Low-Carbohydrate Soy Containing Diet on Systemic Inflammation Among Patients with Nonalcoholic Fatty Liver Disease: A Parallel Randomized Clinical Trial. | 2017 | Details |
| A15687 | 28759733 | Can J Physiol Pharmacol | Protective effect of rimonabant, a canabinoid receptor 1 antagonist, on nonalcoholic fatty liver disease in a rat model through modulation of the hepatic expression of activin A and follistatin. | 2017 | Details |
| A15688 | 28759727 | Can J Physiol Pharmacol | The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells. | 2017 | Details |
| A15689 | 28759632 | PLoS One | Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A15690 | 28759573 | PLoS One | Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis. | 2017 | Details |
| A15691 | 28759276 | J Diet Suppl | Biochemical and Histopathological Evidence on Beneficial Effects of Standardized Extract from Tragopogon graminifolius as a Dietary Supplement in Fatty Liver: Role of Oxidative Stress. | 2017 | Details |
| A15692 | 28758929 | Int J Mol Sci | Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions. | 2017 | Details |
| A15693 | 28758097 | Ann Transl Med | Prognostic value of red blood cell distribution width in hepatocellular carcinoma. | 2017 | Details |
| A15694 | 28758096 | Ann Transl Med | Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. | 2017 | Details |
| A15696 | 28754826 | J Lipid Res | Osteopontin regulates the cross-talk between phosphatidylcholine and cholesterol metabolism in mouse liver. | 2017 | Details |
| A15697 | 28754512 | Int J Pharm | Sustained-release mitochondrial protonophore reverses nonalcoholic fatty liver disease in rats. | 2017 | Details |
| A15698 | 28753963 | Nutrients | The Combined Intervention with Germinated Vigna radiata and Aerobic Interval Training Protocol Is an Effective Strategy for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and Other Alterations Related to the Metabolic Syndrome in Zucker Rats. | 2017 | Details |
| A15699 | 28752920 | Liver Transpl | Outcome of liver transplantation in patients with prior bariatric surgery. | 2017 | Details |
| A15700 | 28752524 | Aliment Pharmacol Ther | Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD. | 2017 | Details |
| A15701 | 28752050 | Mol Metab | Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders. | 2017 | Details |
| A15702 | 28751722 | Sci Rep | Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma. | 2017 | Details |
| A15703 | 28751548 | Diabetes Care | Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial. | 2017 | Details |
| A15704 | 28751453 | J Endocrinol | Maternal modifiers of the infant gut microbiota: metabolic consequences. | 2017 | Details |
| A15705 | 28751149 | Diabetes Metab Syndr | The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. | 2017 | Details |
| A15707 | 28751080 | Med Clin (Barc) | Non-alcoholic fatty liver disease: A poorly known pandemic. | 2017 | Details |
| A15708 | 28750643 | Lipids Health Dis | Isolated hypercholesterolemia leads to steatosis in the liver without affecting the pancreas. | 2017 | Details |
| A15709 | 28750503 | Clin Mol Hepatol | Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals. | 2017 | Details |
| A15710 | 28750085 | PLoS One | Orphan nuclear receptor ERRγ is a key regulator of human fibrinogen gene expression. | 2017 | Details |
| A15712 | 28749418 | Nutrients | The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study. | 2017 | Details |